USA Rare Earth’s Carester Stake Fills the Separation Gap, but Adds Another Commissioning Clock

USA Rare Earth has locked in a 13.6% stake in French processor Carester, giving its emerging mine-to-magnet platform access to a scarce link in the chain: commercial-scale separation of heavy rare earths.

The deal is strategically neat. Carester’s Caremag plant in Lacq is scheduled to begin commissioning in the fourth quarter of 2026 and, once fully ramped, is expected to produce 800 tonnes a year of neodymium-praseodymium oxide, 500 tonnes of dysprosium oxide and 100 tonnes of terbium oxide. USA Rare Earth and its Less Common Metals subsidiary will be able to buy part of that output, while Carester gains access to feedstock from Brazil’s Serra Verde operation and the planned Round Top project in Texas.

That closes a gap that mining announcements often leave unresolved. Rare-earth ore has little strategic value until it is beneficiated, chemically cracked or leached, purified and separated into saleable oxides. Dysprosium and terbium are especially difficult because they occur in small concentrations, require complex separation circuits and are used to preserve magnet performance at high temperatures.

Caremag’s planned Dy and Tb output would equal about 15% of current global production of those two magnetic heavy rare-earth oxides, according to USA Rare Earth. If the plant reaches specification and nameplate output, the stake could give the company a meaningful non-Chinese source of the materials needed for high-performance permanent magnets.

The important word is “if.” USA Rare Earth is assembling several industrial assets at once, and each carries its own commissioning timetable.

The company agreed in April to acquire Serra Verde for about $2.8 billion. Serra Verde’s Pela Ema operation in Brazil is already producing a mixed rare-earth product containing neodymium, praseodymium, dysprosium and terbium, and USA Rare Earth expects Phase 1 to reach roughly 6,400 tonnes of total rare-earth oxide a year by the end of 2027. The acquisition is expected to close in the third quarter of 2026.

In France, Caremag must complete construction, commission solvent-extraction and recycling circuits, establish stable recoveries and consistently meet oxide-purity specifications. USA Rare Earth has not disclosed the final price of the 13.6% stake in its July announcement, while Reuters previously reported that the proposed investment was about €40 million. The portion of Caremag output available to USA Rare Earth and LCM has also not been quantified publicly.

At the same Lacq industrial site, LCM Europe is planning 3,750 tonnes a year of metal and alloy production. Further downstream, USA Rare Earth is ramping a magnet plant in Stillwater, Oklahoma. Those assets create a credible integrated route from Brazilian feedstock to French oxides and alloys and then to finished magnets, but they also create sequencing risk. A delay at one stage can strand working capital or leave another facility short of qualified material.

The Carester investment is also a minority position. It provides commercial access and technical cooperation, not operating control. USA Rare Earth will depend on Carester’s execution, while Carester will need suitable feedstock and customer qualification for its output.

The strategic backdrop is supportive. The European Union wants at least 40% of annual strategic-raw-material consumption processed inside the bloc and at least 25% supplied through recycling by 2030. Europe also wants no more than 65% of any strategic raw material to come from a single third country. Caremag fits all three objectives because it combines separation, recycling and non-Chinese feedstock.

Government support, however, does not remove commercial pressure. China still dominates global rare-earth processing and can influence prices through output and export policy. Western projects therefore need more than strategic labels: they need competitive recoveries, reliable throughput, disciplined capital spending and customers willing to qualify material from new plants.

USA Rare Earth’s earlier Samarium coverage focused on its successful production of commercial-grade dysprosium and NdPr oxides from recycled magnet scrap at Wheat Ridge. The Carester deal is a different step. It moves the company from proving chemistry at demonstration scale toward securing third-party industrial separation capacity.

The next test is execution across four linked milestones: closing Serra Verde, funding the Carester investment, commissioning Caremag and matching oxide output with LCM’s alloy capacity and Stillwater’s magnet ramp. If those clocks stay aligned, USA Rare Earth will have one of the most complete Western rare-earth platforms. If they do not, integration will become a capital burden before it becomes a competitive advantage.